Cancer Immunogene Therapy - Anti - gene anti IGF-I approach. Case of Glioblastoma
5 Angebote vergleichen

Bester Preis: 50,07 (vom 10.10.2017)
1
9783330063457 - Jerzy Trojan: Cancer Immunogene Therapy: Anti – gene anti IGF-I approach. Case of Glioblastoma
Jerzy Trojan

Cancer Immunogene Therapy: Anti – gene anti IGF-I approach. Case of Glioblastoma (2017)

Lieferung erfolgt aus/von: Vereinigte Staaten von Amerika EN PB NW

ISBN: 9783330063457 bzw. 3330063459, in Englisch, 140 Seiten, LAP LAMBERT Academic Publishing, Taschenbuch, neu.

50,08 ($ 58,81)¹ + Versand: 6,79 ($ 7,98)¹ = 56,87 ($ 66,79)¹
unverbindlich

Neu ab: $58.80 (5 Angebote)
Zu den weiteren 5 Angeboten bei Amazon.com

Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 24 hours.
Von Händler/Antiquariat, Amazon.com.
Certain specific antigens, which behave as oncoproteins, are present in normal fetal/neonatal developing brain. It was demonstrated that a convergence exists between ontogenesis and onco-genesis. The most malignant example of central nervous system neoplasia is glioblastoma multiforme. The biomarker – oncoprotein - characteristic of glial fetal and tumoral cells, but not neuronal cells, is IGF-I. For this reason, for therapy purpose, the arrest of IGF-I synthesis in cancer glial cells of glioblastoma was performed using in vitro anti – gene anti IGF-I strategy (IGF-I antisense /triple helix, AS/TH). The created AS/TH cells, became immunogenic and expressed MHC-I, B71 antigens. The AS/TH cells while injected in glioblastoma patients, induced the antitumor immune response and stopped the progression of tumor development. The survival of treated glioblastoma patients reached 2 years, and in some cases, up to 3-4 years. The established Anti - Gene IGF-I cancer immunotherapy was introduced in USA, Europe, China and Latin America. Paperback, Label: LAP LAMBERT Academic Publishing, LAP LAMBERT Academic Publishing, Produktgruppe: Book, Publiziert: 2017-04-04, Freigegeben: 2017-04-04, Studio: LAP LAMBERT Academic Publishing.
2
9783330063457 - Jerzy Trojan: Cancer Immunogene Therapy: Anti – gene anti IGF-I approach. Case of Glioblastoma
Jerzy Trojan

Cancer Immunogene Therapy: Anti – gene anti IGF-I approach. Case of Glioblastoma (2017)

Lieferung erfolgt aus/von: Vereinigte Staaten von Amerika EN PB NW

ISBN: 9783330063457 bzw. 3330063459, in Englisch, 140 Seiten, LAP LAMBERT Academic Publishing, Taschenbuch, neu.

50,07 ($ 58,80)¹ + Versand: 14,43 ($ 16,95)¹ = 64,50 ($ 75,75)¹
unverbindlich

Neu ab: $58.80 (5 Angebote)
Zu den weiteren 5 Angeboten bei Amazon.com

Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 1-2 business days, Tatsächliche Versandkosten können abweichen.
Von Händler/Antiquariat, Book Depository US.
Certain specific antigens, which behave as oncoproteins, are present in normal fetal/neonatal developing brain. It was demonstrated that a convergence exists between ontogenesis and onco-genesis. The most malignant example of central nervous system neoplasia is glioblastoma multiforme. The biomarker – oncoprotein - characteristic of glial fetal and tumoral cells, but not neuronal cells, is IGF-I. For this reason, for therapy purpose, the arrest of IGF-I synthesis in cancer glial cells of glioblastoma was performed using in vitro anti – gene anti IGF-I strategy (IGF-I antisense /triple helix, AS/TH). The created AS/TH cells, became immunogenic and expressed MHC-I, B71 antigens. The AS/TH cells while injected in glioblastoma patients, induced the antitumor immune response and stopped the progression of tumor development. The survival of treated glioblastoma patients reached 2 years, and in some cases, up to 3-4 years. The established Anti - Gene IGF-I cancer immunotherapy was introduced in USA, Europe, China and Latin America. Paperback, Label: LAP LAMBERT Academic Publishing, LAP LAMBERT Academic Publishing, Produktgruppe: Book, Publiziert: 2017-04-04, Freigegeben: 2017-04-04, Studio: LAP LAMBERT Academic Publishing.
3
9783330063457 - Jerzy Trojan: Cancer Immunogene Therapy
Jerzy Trojan

Cancer Immunogene Therapy

Lieferung erfolgt aus/von: Deutschland DE NW

ISBN: 9783330063457 bzw. 3330063459, in Deutsch, neu.

Lieferung aus: Deutschland, Lieferzeit: 6 Tage.
Certain specific antigens, which behave as oncoproteins, are present in normal fetal/neonatal developing brain. It was demonstrated that a convergence exists between ontogenesis and onco-genesis. The most malignant example of central nervous system neoplasia is glioblastoma multiforme. The biomarkeroncoproteincharacteristic of glial fetal and tumoral cells, but not neuronal cells, is IGF-I. For this reason, for therapy purpose, the arrest of IGF-I synthesis in cancer glial cells of glioblastoma was performed using in vitro antigene anti IGF-I strategy (IGF-I antisense /triple helix, AS/TH). The created AS/TH cells, became immunogenic and expressed MHC-I, B71 antigens. The AS/TH cells while injected in glioblastoma patients, induced the antitumor immune response and stopped the progression of tumor development. The survival of treated glioblastoma patients reached 2 years, and in some cases, up to 3-4 years. The established AntiGene IGF-I cancer immunotherapy was introduced in USA, Europe, China and Latin America.
4
9783330063457 - Jerzy Trojan: Cancer Immunogene Therapy
Jerzy Trojan

Cancer Immunogene Therapy

Lieferung erfolgt aus/von: Deutschland DE PB NW

ISBN: 9783330063457 bzw. 3330063459, in Deutsch, 140 Seiten, LAP Lambert Academic Publishing, Taschenbuch, neu.

55,90 + Versand: 1,40 = 57,30
unverbindlich
Von Händler/Antiquariat, Buchhandlung Hoffmann, [3174608].
Neuware - Certain specific antigens, which behave as oncoproteins, are present in normal fetal/neonatal developing brain. It was demonstrated that a convergence exists between ontogenesis and onco-genesis. The most malignant example of central nervous system neoplasia is glioblastoma multiforme. The biomarker - oncoprotein - characteristic of glial fetal and tumoral cells, but not neuronal cells, is IGF-I. For this reason, for therapy purpose, the arrest of IGF-I synthesis in cancer glial cells of glioblastoma was performed using in vitro anti - gene anti IGF-I strategy (IGF-I antisense /triple helix, AS/TH). The created AS/TH cells, became immunogenic and expressed MHC-I, B71 antigens. The AS/TH cells while injected in glioblastoma patients, induced the antitumor immune response and stopped the progression of tumor development. The survival of treated glioblastoma patients reached 2 years, and in some cases, up to 3-4 years. The established Anti - Gene IGF-I cancer immunotherapy was introduced in USA, Europe, China and Latin America. Taschenbuch, Neuware, 220x150x8 mm, 225g, 140, Internationaler Versand, offene Rechnung (Vorkasse vorbehalten), sofortueberweisung.de, Selbstabholung und Barzahlung, Skrill/Moneybookers, PayPal, Lastschrift, Banküberweisung.
5
9783330063457 - Jerzy Trojan: Cancer Immunogene Therapy als von
Jerzy Trojan

Cancer Immunogene Therapy als von

Lieferung erfolgt aus/von: Deutschland DE HC NW

ISBN: 9783330063457 bzw. 3330063459, in Deutsch, LAP Lambert Academic Publishing, gebundenes Buch, neu.

Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…